Literature DB >> 24993975

Association of intercellular adhesion molecule‑1 gene polymorphism with coronary heart disease.

Jun-Yi Luo1, Yi-Tong Ma1, Xiang Xie1, Yi-Ning Yang1, Xiao-Mei Li1, Xiang Ma1, Zixiang Yu1, Bang-Dang Chen2, Fen Liu2.   

Abstract

Intercellular adhesion molecule‑1 (ICAM‑1) is an important adhesion molecule that has a crucial role in lymphocyte migration and atherosclerosis pathogenesis activation. The aim of the present study was to explore the association between the rs5498 polymorphism of the ICAM‑1 gene and coronary heart disease (CHD). The rs5498 polymorphism of the ICAM‑1 gene was detected using polymerase chain reaction‑restriction fragment length polymorphism in 674 patients with CHD and 779 control subjects. The results showed that the frequency of the G allele was significantly higher in patients with CHD than that in controls (29.1 vs. 23.3%; P<0.001). The frequency of the AG+GG genotypes was higher in patients with CHD than that in controls (49.7 vs. 40.8%; P=0.001). Multiple logistic regression analysis showed that AG+GG was an independent risk factor for CHD (odds ratio, 1.919; 95% confidence intervals, 1.471‑2.503; P<0.001). For males, the frequencies of the G allele and AG+GG genotype were also higher in patients with CHD than those in control subjects (frequency of G allele, 29.9 vs. 22.7%; P<0.001; frequency of AG+GG genotype, 50.6 vs. 40.3%; P=0.001). For females, no significant differences in genotype or allele distribution were observed between the two groups. In conclusion, it was demonstrated in the present study that the rs5498 polymorphism of the ICAM‑1 gene was associated with CHD in males. Males with the G allele (AG and GG genotype) may therefore have a higher risk for CHD than those with the AA genotype.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24993975     DOI: 10.3892/mmr.2014.2360

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

Review 1.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

2.  Association between VEGF polymorphisms (936c/t, -460t/c and -634g/c) with haplotypes and coronary heart disease susceptibility.

Authors:  Xia Han; Lili Liu; Jiamin Niu; Jun Yang; Zengtang Zhang; Zhiqiang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease.

Authors:  Dongxing Liu; Jiantao Song; Xianfei Ji; Zunqi Liu; Mulin Cong; Bo Hu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 4.  ICAM-1 gene rs5498 polymorphism decreases the risk of coronary artery disease.

Authors:  Ailing Liu; Ailing Wan; Aifang Feng; Ruping Rui; Bingzhi Zhou
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

5.  Association between the ICAM-1 gene polymorphism and coronary heart disease risk: a meta-analysis.

Authors:  De-Lu Yin; Xin-Hua Zhao; Yi Zhou; Ying Wang; Ping Duan; Qun-Xing Li; Zheng Xiong; Yang-Yang Zhang; Yu Chen; Hong He; Kai Yang; He-Jian Song
Journal:  Biosci Rep       Date:  2019-02-22       Impact factor: 3.840

6.  Letter to the Editor: Comments on "Association between the ICAM-1 gene polymorphism and coronary heart disease risk: a meta-analysis".

Authors:  Morteza Gholami; Mahsa M Amoli; Farshad Sharifi
Journal:  Biosci Rep       Date:  2019-05-17       Impact factor: 3.840

7.  Association between MIF gene promoter rs755622 and susceptibility to coronary artery disease and inflammatory cytokines in the Chinese Han population.

Authors:  Jun-Yi Luo; Bin-Bin Fang; Guo-Li Du; Fen Liu; Yan-Hong Li; Ting Tian; Xiao-Mei Li; Xiao-Ming Gao; Yi-Ning Yang
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

8.  The effect of CYP7B1 polymorphisms on the risk of coronary heart disease in Hainan Han population.

Authors:  Tiebiao Liang; Xianbo Zhang; Anshan Liang; Haiqing Wu; Qi Wang; Jun He; Ming Long; Tianbo Jin
Journal:  BMC Med Genomics       Date:  2021-09-07       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.